This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
NVIDIA's Stock Awaiting $300 Billion Impact? ETFs in Focus
by Sanghamitra Saha
Analysts expect any meaningful changes in upcoming earnings to impact NVIDIA's market capitalization by about $305 billion, as quoted on Reuters.
What's in Store for NVIDIA ETFs in Q2 Earnings?
by Sweta Killa
Many analysts are bullish on the stock ahead of NVIDIA's earnings release.
Zacks Investment Ideas feature highlights: XLK and Nvidia
by Zacks Equity Research
XLK and Nvidia have been highlighted in this Investment Ideas article.
Major Tech ETF Finds Key Support; All Eyes on Nvidia Earnings
by Bryan Hayes
Results out of semiconductor giant Nvidia will have broad implications on the semiconductor industry as well as the AI space.
Immersion (IMMR) Plunges 25% in a Month: Is It Time to Buy the Dip?
by Anirudha Bhagat
The recent dip in the Immersion (IMMR) stock could be a golden opportunity for investors, given its robust fundamentals and promising growth trajectory.
ETF Strategies to Play as Recession Fears Fade
by Yashwardhan Jain
Recessionary fears increased after markets experienced a sharp sell-off in early August. However, driven by improving economic data, recessionary worries have faded, which makes investing in these funds appealing.
Should You Invest in the First Trust Technology AlphaDEX ETF (FXL)?
by Zacks Equity Research
Sector ETF report for FXL
Should You Invest in the iShares Expanded Tech Sector ETF (IGM)?
by Zacks Equity Research
Sector ETF report for IGM
Momentum ETFs to Play as Wall Street Rallies?
by Sanghamitra Saha
Stocks surged higher on Thursday as retail sales showed gains and Fed cues of interest rate cuts.
Will Tech ETFs See Further Selloffs?
by Sanghamitra Saha
U.S. technology stocks are currently under significant pressure, as noted by Citigroup strategists. Here are some tech ETFs to consider.
Is Invesco S&P 500 Equal Weight Technology ETF (RSPT) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RSPT
Should You Buy the Dip in Tech ETFs?
by Sanghamitra Saha
There has been a tech rout on Wall Street. Should you buy the dip in tech ETFs with artificial intelligence (AI) mania still prevalent?
Should You Invest in the Invesco S&P SmallCap Information Technology ETF (PSCT)?
by Zacks Equity Research
Sector ETF report for PSCT
Should You Invest in the Fidelity MSCI Information Technology Index ETF (FTEC)?
by Zacks Equity Research
Sector ETF report for FTEC
ETFs in Focus as Buffett Cuts Apple Stake by Nearly 50%
by Sanghamitra Saha
Buffett's Berkshire Hathaway disclosed a huge reduction in its stake in Apple (AAPL) in its second-quarter earnings report released recently.
Should You Invest in the SPDR NYSE Technology ETF (XNTK)?
by Zacks Equity Research
Sector ETF report for XNTK
Is First Trust NASDAQ-100-Technology Sector ETF (QTEC) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for QTEC
ETF Areas to Focus on in a Goldilocks US Economy
by Sanghamitra Saha
A Goldilocks economy is the one that has been witnessing steady economic growth but not so much that it can stoke inflation.The US economy is currently in this situation.
Microsoft ETFs Tumble as Q3 Cloud Growth Slows Down
by Sweta Killa
Though Microsoft (MSFT) beat earnings and revenue estimates, growth in Azure cloud computing slowed down. Microsoft also offered weak guidance for the ongoing quarter.
Should You Invest in the Vanguard Information Technology ETF (VGT)?
by Zacks Equity Research
Sector ETF report for VGT
Should You Invest in the iShares U.S. Technology ETF (IYW)?
by Zacks Equity Research
Sector ETF report for IYW
Microsoft Gears Up for Earnings After the Bell: ETFs in Focus
by Sweta Killa
ft (MSFT) is set to release fourth-quarter 2024 results today after market close. The software maker has a reasonable chance of beating estimates in the reported quarter.
Should You Invest in the Invesco Dorsey Wright Technology Momentum ETF (PTF)?
by Zacks Equity Research
Sector ETF report for PTF
Immersion (IMMR) Hits 52-Week High: What's Next for Investors?
by Anirudha Bhagat
Immersion's (IMMR) unique products, competitive advantage, continuous deal wins and robust financial performance make it an attractive investment opportunity.
Time for Healthcare ETFs?
by Sanghamitra Saha
Compelling valuation, innovation in specific growth areas and an aging population as well as increasing healthcare spending are the tailwinds of the medical sector.